Loading...
•
Jun 30
AirSculpt Q2 2025 Earnings Report
AirSculpt narrowed its year-over-year revenue decline in Q2 2025, reporting improved adjusted EBITDA and increased consumer engagement.
Key Takeaways
AirSculpt's Q2 2025 results showed a 13.7% decline in revenue, but the company reduced its net loss and grew leads and consultations. Case volume dropped year-over-year, yet margin remained stable, and the business maintained its full-year outlook. The company also strengthened its balance sheet by reducing debt through a stock offering.
Revenue declined to $44.0 million, down 13.7% year-over-year.
Case volume fell 14.1% to 3,392, but revenue per case remained stable at $12,975.
Adjusted EBITDA was $5.8 million with a margin of 13.3%.
Cash and cash equivalents totaled $8.2 million at quarter end.
AirSculpt
AirSculpt
Forward Guidance
AirSculpt reaffirmed its full-year 2025 revenue and adjusted EBITDA guidance, supported by a strategy focused on consumer engagement, operational efficiency, and strategic offerings.
Positive Outlook
- Full-year revenue guidance reaffirmed at $160–$170 million.
- Adjusted EBITDA forecast remains $16–$18 million.
- Record level of leads and meaningful increase in consultations.
- Debt reduced by $16 million through equity raise.
- New offerings piloted in skin tightening and financing options.
Challenges Ahead
- Case volume down 14.1% year-over-year.
- Revenue dropped 13.7% compared to Q2 2024.
- Same-center case volume declined 22%.
- Adjusted EBITDA decreased from $6.9M to $5.8M.
- Net loss, although narrowed, still at $0.6 million.